APLLTD.NSE Alembic Pharmaceuticals Ltd

ICICI Securities recommended reduce rating on Alembic Pharma with a target price of Rs 705 in its research report dated August 07, 2023.

Nippon Life has seen a breakout of horizontal resistance trendline adjoining highs of June 30 and July 12, and formed a bullish candlestick pattern on the daily timeframe with above average volumes. Further, it has also seen a golden crossover this month.

The momentum is expected to take the index up to 19,000 mark in the coming days, with immediate support at 18,800, then 18,700-18,500 area, experts said